Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

88.84
Delayed Data
As of 4:14pm ET
 -0.28 / -0.31%
Today’s Change
75.90
Today|||52-Week Range
134.71
-29.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues309.8M417.9M398.1M431.6M
 
 
 
 
 
Cost of Goods Sold15.8M48.7M34.2M30.3M
 
 
 
 
 
Depreciation And Amortization16.2M15.7M16.4M15.0M
 
 
 
 
 
 
Operating ExpensesGross Income277.9M353.5M347.4M386.4M
 
 
 
 
 
General Expenses346.1M407.5M361.1M382.7M
 
 
 
 
 
Research And Development246.3M310.4M255.9M271.0M
 
 
 
 
 
Total Operating Expenses378.0M471.9M411.7M427.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-68.2M-54.0M-13.6M3.7M
 
 
 
 
 
Extraordinary Charge-1.8M-1.5M-687.0K-343.0K
 
 
 
 
 
Interest Expense On Debt21.1M20.7M20.7M20.2M
 
 
 
 
 
Other Expenses-1.3M-1.7M4.4M-1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-92.5M-77.8M-30.6M-18.0M
 
 
 
 
 
Income Taxes-1.3M-1.4M-5.5M-18.1M
 
 
 
 
 
Minority Interest-1.3M-938.0K-5.5M-28.4M
 
 
 
 
 
Net Income-95.1M-75.5M-41.6M-64.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS242.0M243.0M243.8M244.5M
 
 
 
 
 
Shares To Calculate EPS Diluted242.0M243.0M243.8M244.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.39-$0.31-$0.17-$0.26
 
 
 
 
 
EPS Diluted-$0.39-$0.31-$0.17-$0.26